Sintx Stock (NASDAQ:SINT)
Previous Close
$2.18
52W Range
$2.01 - $105.80
50D Avg
$3.19
200D Avg
$9.68
Market Cap
$1.52M
Avg Vol (3M)
$1.19M
Beta
1.37
Div Yield
-
SINT Company Profile
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
SINT Performance
Peer Comparison
| Ticker | Company |
|---|---|
| INVO | INVO Bioscience, Inc. |
| NXL | Nexalin Technology, Inc. |
| TIVC | Tivic Health Systems, Inc. |
| NUWE | Nuwellis, Inc. |
| IRIX | IRIDEX Corporation |
| RSLS | ReShape Lifesciences Inc. |
| BBLG | Bone Biologics Corporation |
| BJDX | Bluejay Diagnostics, Inc. |
| MOTS | Motus GI Holdings, Inc. |
| HSDT | Helius Medical Technologies, Inc. |
| NAOV | NanoVibronix, Inc. |